Clinical Trials Logo
  1. Home
  2. Gastrointestinal Neoplasms
  3. NCT03050333
  4. Details
NCT03050333 Clinical Trial

Efficacy and Safety of Endoscopic Resection

Gastrointestinal Neoplasms Clinical Trial

Official title:
Efficacy and Safety of Endoscopic Resection

Clinical Trial Details — Status: Recruiting

Administrative data
NCT number NCT03050333
Other study ID # ALB-RME-2013-01
Secondary ID
Status Recruiting
Phase N/A
First received February 3, 2017
Last updated February 9, 2017
Start date April 25, 2013
Est. completion date December 31, 2023

Study information
Verified date February 2017
Source Fundacion Miguel Servet
Contact EDUARDO ALBENIZ, MD
Email edualbeniz@hotmail.com
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

An observational, prospective, multicentre and international study. This will be a non-interventional study to evaluate the efficacy and safety of endoscopic resection of gastrointestinal lesions and to determine what are the factors related to complications, and to describe these lesions according to the different morphologic and histologic classifications.

Recruitment information / eligibility
Status Recruiting
Enrollment 3000
Est. completion date December 31, 2023
Est. primary completion date December 31, 2022
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Female and male patients who are at least 18 years old.

- Clinical indication for endoscopic exam and endoscopic resection

- Patients must freely accept their involvement in this study. They shall give a written informed consent

Exclusion Criteria:

- Patients who do not desire to be included in this study

Study Design

Related Conditions & MeSH terms

Locations
Country Name City State
Spain Eduardo Albeniz Arbizu Pamplona Navarra

Sponsors (2)
Lead Sponsor Collaborator
EDUARDO ALBENIZ Fundacion Miguel Servet

Country where clinical trial is conducted

Spain, 

Outcome
Type Measure Description Time frame Safety issue
Primary Proportion of complete resections without recurrence 6 month post-endoscopic resection
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05551052 - CRC Detection Reliable Assessment With Blood
Terminated NCT01624090 - Mithramycin for Lung, Esophagus, and Other Chest Cancers Phase 2
Completed NCT05178095 - Artificial Intelligence in Colonic Polyp Detection N/A
Recruiting NCT03602677 - Indocyanine Green Fluorescence Imaging in Prevention of Colorectal Anastomotic Leakage N/A
Not yet recruiting NCT05552729 - Effects of Different Doses of Vitamin D on Cancer-related Cognitive Impairment in Patients With Gastrointestinal Tumors Phase 1/Phase 2
Recruiting NCT02871245 - Clinical Trial on Acupuncture Therapy in Patients With Gastrointestinal Neoplasms Laparoscopic Surgery N/A
Not yet recruiting NCT02860429 - Clinical Trial of Cinobufacini Injection Combined With Oxaliplatin Regimen on Gastrointestine Carcinoma Phase 4
Completed NCT04694521 - Outcomes of Side-to-end Versus End-to-end Colorectal Anastomosis in Non-emergent Sigmoid and Rectal Cancers: Randomized Controlled Clinical Trial N/A
Completed NCT02454647 - Induction Chemotherapy, Chemoradiotherapy and Surgery in Locally Advanced Gastric Cancer Patients N/A
Recruiting NCT02196935 - Los Angeles Prospective GI Biliary and EUS Series
Completed NCT00190801 - Phase 2 Study on Use of a Combination of Pemetrexed in Patients With Advanced Gastric Carcinoma Phase 2
Completed NCT00289445 - Study With Mitomycin c/5-FU/FA in Pretreated Gastrointestinal Cancer Patients With Metastases (>= Second-line Treatment) Phase 1/Phase 2
Completed NCT04010227 - Telephone Support for Advanced Gastrointestinal Cancer Patients and Caregivers N/A
Recruiting NCT03330964 - Clinical Trial of Electroacupuncture Stimulation on Prevention and Treatment of Oxaliplatin Neurotoxicity N/A
Recruiting NCT04907643 - Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes N/A
Recruiting NCT05322486 - Palliative Primary Tumor Resection in Minimally Symptomatic Patients With Colorectal Cancer and Synchronous Unresectable Metastases
Completed NCT03559543 - Evaluation of Ocoxin®-Viusid® in Metastatic Colorectal Adenocarcinoma Phase 2
Completed NCT03549494 - Evaluation of Ocoxin®-Viusid® in Advanced Stomach Cancer and Gastric Esophagogastric Junction Phase 2
Recruiting NCT02672774 - Novel Endoscopic Imaging Methods for the Evaluation of Blood Vessels in Gastrointestinal Cancers N/A
Completed NCT02444572 - Comparison of Thromboembolic Events in Patients Undergoing Thromboprophylactic Treatment With ENOXA® vs Lovenox® Phase 4

External Links